INDUSTRY SYMPOSIA

INDUSTRY SYMPOSIA

SUNDAY 4 MARCH 2018

Past, present and future of schizophrenia negative symptoms treatment

SYMPOSIA IS ORGANISED AND SUPPORTED BY 

GEDEON RICHTER and RECORDATI S.P.A

13:15–14:45, CALLIOPE

Negative symptoms of Schizophrenia:

István Bitter (Hungary)

Schizophrenia negative symptoms: A burden for patients, caregivers and society

Silvana Galderisi (Italy)

Dopamine receptor partial agonism: State of the art

Leslie Citrome (USA)

Treatment of schizophrenia negative symptoms: Do we have an adequate solution?

Stefan Leucht (Germany)

SUNDAY 4 MARCH 2018

The reality of treatment-resistant depression (TRD) today

SYMPOSIA IS ORGANISED AND SUPPORTED BY Janssen

13:15–14:45, HERMES

Chair: Siegfried Kasper(Austria)

Identification and diagnosis of patients with TRD:

Siegfried Kasper(Austria)

Biomarkers for TRD: do we have strong evidence?

 Marion Leboyer

Clinical pathways for patients with TRD

Siegfried Kasper(Austria)

SUNDAY 4 MARCH 2018

Is it ADHD? What to look for and what to do…

SYMPOSIA IS ORGANISED AND SUPPORTED BY SHIRE

13:15–14:45, Athena

Chair: David Bull (UK)

Welcome and overview

Dr. David Bull (UK)

ADHD in adults

Anthony Rostain (USA)

ADHD - missed or misdiagnosis? What to look out for…

Larry Klassen (Canada)

Guidance for treatment of ADHD in adults

Philip Asherson (UK)

Ask the Experts: Panel and delegates Q&A

Dr. David Bull (UK), Anthony Rostain (USA), Larry Klassen (Canada), Philip Asherson (UK), Martin Katzman (Canada)

MONDAY 5 MARCH 2018

"Insights into schizophrenia today: do the available treatment options meet patients and physicians' needs?"

SYMPOSIA IS ORGANISED AND SUPPORTED BY ANGELINI

13:15–14:45, CALLIOPE

Chair:  Prof. Andrea Fagiolini (ITALY)

"Patients' and doctors' needs: common goals for a therapeutic alliance".

Christoph Correll (GERMANY)

Current treatment options in light of unmet clinical needs

Stefan Leucht (GERMANY)

Optimizing patient's pharmacological journey in schizophrenia

David Taylor (UK)

MONDAY 5 MARCH 2018

Reducing relapse and mortality in schizophrenia: myth or reality?

SYMPOSIA IS ORGANISED AND SUPPORTED BY Janssen

13:15–14:45, ATHENA

Chair:  John M. Kane (USA)

Welcome and introduction

John M. Kane (USA)

Relapse prevention: would this impact patients' lives? (Including 10 minutes Q&A)

Eric Fakra (France)

Mortality in schizophrenia: do we need to think about that now? (Including 10 minutes Q&A)

Jari Tiihonen (Sweden)

Communicating with patients and caregivers: the role of the treating physician (Including 10 minutes Q&A)

Giuseppe Maina (Italy)

Closing remarks

John M. Kane (USA)

MONDAY 5 MARCH 2018

Functional recovery from depression: lots to THINC® about

SYMPOSIA IS ORGANISED AND SUPPORTED BY Lundbeck

13:15–14:45, HERMES

Chair: Roger McIntyre (CANADA)

Functional recovery in depression: role of cognitive symptoms

Roger McIntyre (CANADA)

Assessment of functional and cognitive outcomes in depression

John Harrison, UK

Clinical management of cognitive symptoms in depression

Bernhard Baune (AUSTRALIA)

A case with vortioxetine and workplace productivity in patients with depression

Pratap Chokka (CANADA)

Questions from the audience

Chair's closing remarks

Roger McIntyre (CANADA)

MONDAY 5 MARCH 2018

FROM CONVENTIONAL ANTIDEPRESSANT EFFICACY TO REAL-WORLD EFFECTIVENESS

SYMPOSIA IS ORGANISED AND SUPPORTED BY Lundbeck

18:45–20:15, HERMES

Chair: Eduard Vieta (SPAIN)

Traditional efficacy of antidepressants: does it reflect your long-term treatment goals? 

Eduard Vieta (SPAIN)

New Rigorous Preclinical Trials of Cerebrolysin for Stroke

Michael Chopp, USA

Looking beyond MADRS to restore patient functioning

Bernhard Baune (AUSTRALIA)

A case with vortioxetine and workplace productivity in patients with depression

Pratap Chokka (CANADA)

Questions from the audience

Chair's closing remarks

Eduard Vieta (SPAIN)

MONDAY 5 MARCH 2018

Interactive Educational Session: Discovering ADHD in Adults

S.T.A.R.T. Clinic (Stress, Trauma, Anxiety, Rehabilitation and Treatment)

SYMPOSIA IS ORGANISED AND SUPPORTED BY SHIRE R&D

Martin Katzman (Canada)

MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry

Philip Asherson (UK)

University of Pennsylvania

Anthony Rostain (USA)

West London Mental Health Services

Susan Young (UK)

Hospital Universitari Vall d'Hebron & Universitat Autonoma de Barcelona

Josep Antoni Ramos-Quiroga (Spain)129

TUESDAY, 6 MARCH 2018

Educational Workshop: General principles and particular cases in the treatment of schizophrenia

SYMPOSIA IS ORGANISED AND SUPPORTED BY EISAI

13:15 – 13:55 | RISSO 6A-B

 Spekaer: Dr Philippe Nuss (France)



Keep Me Updated